Last quarter (Q3 2024), Heart Test Laboratories, Inc.'s total revenue was $14.70K, an increase of 653.85% from the same quarter last year. In Q3, Heart Test Laboratories, Inc.'s net income was $-1.64M. See Heart Test Laboratories, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Apr 23	Apr 22	Apr 21	Apr 20
Total Revenue	$ 18.60K	$ 5.15K	$ 14.37K	$ 25.60K	$ 64.18K
Cost of Revenue	$ 8.88K	-	$ 7.89K	$ 10.66K	$ 46.46K
Gross Profit	$ 15.31K	$ 5.15K	$ 6.48K	$ 14.94K	$ 17.72K
Operating Expense	$ 15.07M	$ 6.12M	$ 4.72M	$ 2.58M	$ 3.84M
Operating Income	$ -6.02M	$ -6.11M	$ -4.71M	$ -2.57M	$ -3.82M
Net Non Operating Interest Income Expense	$ -367.10K	$ -243.17K	$ -371.62K	$ -132.45K	$ -2.81K
Other Income Expense	$ -334.00	$ -1.85K	$ 252.76K	$ 248.41K	$ 9.88K
Pretax Income	$ -6.39M	$ -6.35M	$ -4.83M	$ -2.45M	$ -3.81M
Tax Provision	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -6.39M	$ -6.35M	$ -4.83M	$ -2.45M	$ -3.81M
Basic EPS	$ -0.46	$ -0.80	$ -0.60	$ -0.30	$ -0.47
Diluted EPS	$ -0.46	$ -0.80	$ -0.60	$ -0.30	$ -0.47
Basic Average Shares	$ 83.01M	$ 7.95M	$ 8.11M	$ 8.04M	$ 8.04M
Diluted Average Shares	$ 83.01M	$ 7.95M	$ 8.11M	$ 8.04M	$ 8.04M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 15.08M	$ 6.12M	$ 4.72M	$ 2.59M	$ 3.88M
Net Income From Continuing And Discontinued Operation	$ -6.39M	$ -6.35M	$ -4.83M	$ -2.45M	$ -3.81M
Normalized Income	$ -6.00M	$ -5.02M	$ -5.08M	$ -2.70M	$ -3.82M
Interest Expense	-	-	$ 371.62K	$ 132.45K	$ 2.81K
EBIT	$ -6.02M	$ -6.11M	$ -4.46M	$ -2.32M	$ -3.81M
EBITDA	$ -5.90M	$ -6.02M	$ -4.43M	$ -2.29M	$ -3.74M

Currency in USD

Heart Test Laboratories, Inc. Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing